Their studies and practices in the IOZK indicated that DCs loaded with the lysate of NDV-infected tumor cells (viral oncolysate, VOL) triggered potent anti-tumor immunity by promoting the secretion of IFN-γ and IL-2 from T-cells. This evidence concerns the gene IL2 and neoplasm.